article_metadata: Elena María Vida Navas Alberto Martínez Lorca Aintzane Sancho Gutiérrez Lucia Sanz Gómez Teresa Navarro Martínez Enrique Grande Pulido Alfredo Carrato Mena Pablo Gajate Borau
article_metadata: 10.3389/fendo.2021.676973
article_metadata: Front Endocrinol (Lausanne)
article_metadata: 2021 Apr 15;12:676973.
article_metadata: lu-dotatate case report neuroendocrine neoplasms neuroendocrine tumors peptide receptor radionuclide therapy
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/33935979/
article_metadata: Bone Neoplasms / radiotherapy Neuroendocrine Tumors / radiotherapy Octreotide / analogs & derivatives Organometallic Compounds / therapeutic use Radiopharmaceuticals / therapeutic use Rectal Neoplasms / radiotherapy
article_metadata: Bone Neoplasms / radiotherapy Neuroendocrine Tumors / radiotherapy Octreotide / analogs & derivatives Organometallic Compounds / therapeutic use Radiopharmaceuticals / therapeutic use Rectal Neoplasms / radiotherapy Case Reports Adult Antineoplastic Agents / therapeutic use Bone Neoplasms / diagnostic imaging Bone Neoplasms / drug therapy Bone Neoplasms / secondary Everolimus / therapeutic use Humans Magnetic Resonance Imaging Male Neuroendocrine Tumors / diagnostic imaging Neuroendocrine Tumors / drug therapy Neuroendocrine Tumors / secondary Octreotide / therapeutic use Rectal Neoplasms / diagnostic imaging Rectal Neoplasms / drug therapy Rectal Neoplasms / pathology Retreatment Sunitinib / therapeutic use Tomography, X-Ray Computed Antineoplastic Agents Organometallic Compounds Radiopharmaceuticals Everolimus lutetium Lu 177 dotatate Octreotide Sunitinib
article_metadata: PMC8082310
article_metadata: 33935979
article_metadata: Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors
article_metadata: 2021